前收市價 | 21.83 |
開市 | 22.38 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 22.37 - 22.50 |
52 週波幅 | 16.65 - 22.50 |
成交量 | |
平均成交量 | 1,598 |
市值 | 92.194B |
Beta 值 (5 年,每月) | 0.27 |
市盈率 (最近 12 個月) | 16.54 |
每股盈利 (最近 12 個月) | 1.36 |
業績公佈日 | 2024年7月31日 |
遠期股息及收益率 | 0.75 (3.35%) |
除息日 | 2024年5月16日 |
1 年預測目標價 | 無 |
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th
A covered call strategy is one way to slightly reduce the risk on a long stock position while also generating some premium. Further upside in a covered call position in GSK stock is limited above the covered call strike. Let's look at how a covered call trade on GSK, formerly known as GlaxoSmithKline and based in the UK, might take shape.
GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript May 4, 2024 GSK plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Nick Stone: Hello everyone. Welcome to today’s call and webcast. The presentation was sent to our distribution list by email, and […]